Beacon Investment Advisory Services Inc. Sells 4,166 Shares of NVIDIA Co. (NASDAQ:NVDA)
Beacon Investment Advisory Services Inc. reduced its stake in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 1.2% during the 4th quarter, according to its most recent filing with the Securities ...
Joann Fabrics stores closing across the country. How did the craft store giant get here?
As Hudson-based Joann plans to close 500 of its roughly 850 stores in the U.S., we took a look back at how the retail chain ...
Flathead Beacon1d
Whitefish’s Jake Sanderson Joins Team USA for NHL’s 4 Nations Face-Off Tournament
News broke earlier this week that Ottawa Senators’ defenseman Jake Sanderson, who is originally from Whitefish, has been ...
Is Beacon Building Products (BECN) the Best Industrial Distribution Stock to Buy According to Hedge Funds?
Beacon Building Products (NASDAQ:BECN) is a provider of commercial and residential roofing, windows, decking, insulation, ...
Pliant stock jumps 28% on bexotegrast study update
Pliant Therapeutics (PLRX) stock jumped 21% Thursday after the company issued an update for a Phase 2b clinical study of ...
Hosted on MSN1d
Beacon Roofing's Stock In Focus As QXO's Buyout Offer Gets Regulatory Nod: Retail Sentiment Brightens
Shares of Beacon Roofing Supply ($BECN) were in the spotlight on Wednesday after technology solutions company QXO Inc. said ...
MDM2d
QXO Commences $11B Takeover Bid for Beacon
Meanwhile, QXO maintains that its offer of $124.25 per share is 17% higher than the Beacon stock has ever traded; represents a 37% premium over the 90-day unaffected stock price; and represents a 26% ...
QXO Seeks to Replace Beacon Roofing Board After Bid Snubbed
QXO Inc. is putting forth a slate to replace Beacon Roofing Supply Inc.’s board of directors after its takeover offer was ...
Pliant Therapeutics: Strange Volatility
Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.
With No Competing Offers, Beacon Roofing’s Board Stalls and Misleads
Sold Shares Well Below Offer Price, Undermining Beacon’s Case Against QXOQXO Calls on Beacon Roofing to Let Shareholders ...
Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues
Pliant Therapeutics halted new enrollment in its BEACON-IPF trial after a safety board review. A separate study showed ...
QXO says Beacon’s board ‘stalls and misleads’ in letter to shareholders
QXO (QXO) released a letter to Beacon Roofing Supply (BECN) shareholders regarding its $124.25 per share all-cash offer, which read in part, ...